Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dariusz Pytel

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|March 25, 2020
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative DiseasesWioletta Rozpędek-Kamińska, Natalia Siwecka, Adam Wawrzynkiewicz, et al.
Mutation Research|January 4, 2006
Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repairIreneusz Majsterek, Tomasz Sliwinski, Tomasz Poplawski, et al.
Biomed Research International|April 21, 2015
Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes associated with the neurodegeneration process in the pathogenesis of primary open angle glaucomaAlicja Nowak, Ireneusz Majsterek, Karolina Przybyłowska-Sygut, et al.
Current Medicinal Chemistry|January 19, 2018
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer TreatmentWioletta Rozpędek, Dariusz Pytel, Alicja Nowak-Zduńczyk, et al.
Current Cancer Drug Targets|January 8, 2020
Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal CancerWioletta Rozpędek, Dariusz Pytel, Adam Wawrzynkiewicz, et al.
International Journal of Molecular Sciences|January 23, 2024
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal AstrocytesWioletta Rozpędek-Kamińska, Grzegorz Galita, Kamil Saramowicz, et al.
International Journal of Molecular Sciences|September 8, 2019
Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in CarcinogenesisNatalia Siwecka, Wioletta Rozpędek, Dariusz Pytel, et al.
Polski Przeglad Chirurgiczny|December 5, 2022
Small-molecule inhibitors of the PERK-mediated Unfolded Protein Response signaling pathway in targeted therapy for colorectal cancerWioletta Rozpedek-Kaminska, Danuta Piotrzkowska, Grzegorz Galita, et al.
Molecular Carcinogenesis|November 22, 2016
The role of base excision repair in pathogenesis of breast cancer in the Polish populationMagda Cuchra, Bartosz Mucha, Lukasz Markiewicz, et al.
Cytotechnology|January 6, 2019
Induction of apoptosis by in vitro and in vivo plant extracts derived from Menyanthes trifoliata L. in human cancer cellsTomasz Kowalczyk, Przemysław Sitarek, Ewa Skała, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|March 25, 2020
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative DiseasesWioletta Rozpędek-Kamińska, Natalia Siwecka, Adam Wawrzynkiewicz, et al.
Mutation Research|January 4, 2006
Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repairIreneusz Majsterek, Tomasz Sliwinski, Tomasz Poplawski, et al.
Biomed Research International|April 21, 2015
Analysis of the expression and polymorphism of APOE, HSP, BDNF, and GRIN2B genes associated with the neurodegeneration process in the pathogenesis of primary open angle glaucomaAlicja Nowak, Ireneusz Majsterek, Karolina Przybyłowska-Sygut, et al.
Current Medicinal Chemistry|January 19, 2018
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer TreatmentWioletta Rozpędek, Dariusz Pytel, Alicja Nowak-Zduńczyk, et al.
Current Cancer Drug Targets|January 8, 2020
Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal CancerWioletta Rozpędek, Dariusz Pytel, Adam Wawrzynkiewicz, et al.
International Journal of Molecular Sciences|January 23, 2024
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal AstrocytesWioletta Rozpędek-Kamińska, Grzegorz Galita, Kamil Saramowicz, et al.
International Journal of Molecular Sciences|September 8, 2019
Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in CarcinogenesisNatalia Siwecka, Wioletta Rozpędek, Dariusz Pytel, et al.
Polski Przeglad Chirurgiczny|December 5, 2022
Small-molecule inhibitors of the PERK-mediated Unfolded Protein Response signaling pathway in targeted therapy for colorectal cancerWioletta Rozpedek-Kaminska, Danuta Piotrzkowska, Grzegorz Galita, et al.
Molecular Carcinogenesis|November 22, 2016
The role of base excision repair in pathogenesis of breast cancer in the Polish populationMagda Cuchra, Bartosz Mucha, Lukasz Markiewicz, et al.
Cytotechnology|January 6, 2019
Induction of apoptosis by in vitro and in vivo plant extracts derived from Menyanthes trifoliata L. in human cancer cellsTomasz Kowalczyk, Przemysław Sitarek, Ewa Skała, et al.
Pageof 5